These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7138584)

  • 1. Effect of ARA-C incorporation on deoxyribonucleic acid synthesis in cells.
    Major PP; Egan EM; Herrick DJ; Kufe DW
    Biochem Pharmacol; 1982 Sep; 31(18):2937-40. PubMed ID: 7138584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 1-beta-D-arabinofuranosylcytosine incorporation on eukaryotic DNA template function.
    Kufe DW; Munroe D; Herrick D; Egan E; Spriggs D
    Mol Pharmacol; 1984 Jul; 26(1):128-34. PubMed ID: 6431261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between incorporation of 9-beta-D-arabinofuranosyladenine in L 1210 DNA and cytotoxicity.
    Kufe DW; Major PP; Munroe D; Egan M; Herrick D
    Cancer Res; 1983 May; 43(5):2000-4. PubMed ID: 6831429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the mechanism of action of cytosine arabinoside.
    Kufe DW; Major PP
    Med Pediatr Oncol; 1982; 10 Suppl 1():49-67. PubMed ID: 6761569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of cytotoxicity with incorporation of ara-C into DNA.
    Kufe DW; Major PP; Egan EM; Beardsley GP
    J Biol Chem; 1980 Oct; 255(19):8997-900. PubMed ID: 7410404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of cell-cycle information in the preparation of drug combinations: results with cytosine arabinoside plus actinomycin D1,2.
    Bhuyan BK; Fraser TJ; Day KJ
    Cancer Treat Rep; 1976 Dec; 60(12):1813-8. PubMed ID: 1036090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of thymidine-enhanced incorporation of ara-C in deoxyribonucleic acid with increased cell kill.
    Major PP; Sargent L; Egan EM; Kufe DW
    Biochem Pharmacol; 1981 Aug; 30(16):2221-4. PubMed ID: 7295337
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacology of combination chemotherapy of cytosine arabinoside (ara-C) and uracil arabinoside (ara-U) or tetrahydrouridine (THU) against murine leukemia L1210/0 in tumor-bearing mice.
    Avramis VI; Powell W
    Cancer Invest; 1987; 5(4):293-9. PubMed ID: 3664332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incorporation of 1-beta-D-arabinofuranosylcytosine into DNA from herpes simplex virus resistant to 9-beta-D-arabinofuranosyladenine.
    Kufe D; Herrick D; Crumpacker C; Schnipper L
    Cancer Res; 1984 Jan; 44(1):69-73. PubMed ID: 6317173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alkali lability of deoxyribonucleic acid that contains adenine arabinoside.
    Egan EM; Justi-Wheeler H; Kufe DW
    Biochem Pharmacol; 1983 Dec; 32(24):3849-52. PubMed ID: 6661257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism and selective effects of 1-beta-D-arabinofuranosylcytosine in L1210 and Host tissues in vivo.
    Chou TC; Hutchinson DJ; Schmid FA; Philips FS
    Cancer Res; 1975 Jan; 35(1):225-36. PubMed ID: 1109791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 1-beta-D-arabinofuranosylcytosine on DNA replication intermediates monitored by pH-step alkaline elution.
    Ross DD; Chen SR; Cuddy DP
    Cancer Res; 1990 May; 50(9):2658-66. PubMed ID: 2328491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of cytosine arabinoside resistant cells at low frequency using the bromodeoxyuridine/DNA assay.
    Waldman FM; Dolbeare F; Gray JW
    Cytometry; 1985 Nov; 6(6):657-62. PubMed ID: 4064845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporation of 9-beta-D-arabinofuranosyl-2-fluoroadenine into HL-60 cellular RNA and DNA.
    Spriggs D; Robbins G; Mitchell T; Kufe D
    Biochem Pharmacol; 1986 Jan; 35(2):247-52. PubMed ID: 3942598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Instability of (ara-C) DNA under alkaline conditions.
    Major PP; Egan EM; Herrick D; Kufe DW
    Biochem Pharmacol; 1982 Mar; 31(5):861-6. PubMed ID: 7200770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence-specific effects of ara-5-aza-CTP and ara-CTP on DNA synthesis by purified human DNA polymerases in vitro: visualization of chain elongation on a defined template.
    Townsend AJ; Cheng YC
    Mol Pharmacol; 1987 Sep; 32(3):330-9. PubMed ID: 2444869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of synergistic cell killing when methotrexate precedes cytosine arabinoside: study of L1210 and human leukemic cells.
    Cadman E; Eiferman F
    J Clin Invest; 1979 Sep; 64(3):788-97. PubMed ID: 288743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of murine L1210 lymphoid leukemia and melanoma B16 with lipophilic cytosine arabinoside prodrugs incorporated into unilamellar liposomes.
    Rubas W; Supersaxo A; Weder HG; Hartmann HR; Hengartner H; Schott H; Schwendener R
    Int J Cancer; 1986 Jan; 37(1):149-54. PubMed ID: 3941019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 1-beta-D-arabinofuranosylcytosine incorporation on elongation of specific DNA sequences by DNA polymerase beta.
    Ohno Y; Spriggs D; Matsukage A; Ohno T; Kufe D
    Cancer Res; 1988 Mar; 48(6):1494-8. PubMed ID: 3345522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sensitive new method for clinically monitoring cytarabine concentrations at the DNA level in leukemic cells.
    Yamauchi T; Ueda T
    Biochem Pharmacol; 2005 Jun; 69(12):1795-803. PubMed ID: 15935150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.